Effects of growth hormone and insulin-like growth factor-1 on postoperative muscle and substrate metabolism.
This study explored if a combined supplementation of GH and IGF-1 had an additive effect on whole body nitrogen economy, energy, substrate and skeletal muscle metabolism following surgical trauma. Patients were randomized to controls (C; n = 10), to GH (0.15 IU/kg/injection) (GH; n = 7) or GH combined with IGF-1 (40 mug/kg/injection) subcutaneously twice a day (GH-IGF-1; n = 9) together with standardized parenteral nutrition. Muscle amino acids, glutathione and the ribosomal pattern reflecting protein synthesis, and nitrogen balance were measured. GH- and GH-IGF-1 groups showed lower urea and higher plasma glucose concentrations. Energy expenditure increased in the GH-group. GH-IGF-1 prevented a decrease in muscle polyribosomes indicating a preserved muscle protein synthesis. In the GH group unaltered BCAA and AAA levels were seen in muscle indicating an unchanged protein breakdown, while the other groups showed increased muscle concentrations postoperatively. Without statistically difference GH marginally improved the nitrogen balance, in terms of higher values, and growth factors improved the nitrogen balance when the shift in urea was taken into account. To conclude, growth factors influences urea metabolism, protein degradation and protein synthesis. There was no clearcut additional effect when combining GH and IGF-1 but the study was probably underpowered to outrule this and effects on nitrogen balance.
Hammarqvist
Folke
F
Gastrocentrum, Karolinska University Hospital Huddinge, K53, S-141 86 Stockholm, Sweden.
Wennström
Ingmar
I
Wernerman
Jan
J
J Clin Endocrinol Metab. 1998 Jul;83(7):2509-15
9661636
J Clin Endocrinol Metab. 1999 Apr;84(4):1311-23
10199772
Ann Surg. 1992 Aug;216(2):184-91
1503519
Ann Surg. 1993 Oct;218(4):400-16; discussion 416-8
8215633
J Clin Endocrinol Metab. 1998 May;83(5):1566-72
9589657
Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E151-7
12759221
Ann Surg. 1988 Jul;208(1):6-16
3133995
Clin Sci (Lond). 2003 Mar;104(3):275-82
12605586
J Clin Endocrinol Metab. 2000 Jan;85(1):183-92
10634385
Clin Endocrinol (Oxf). 1991 Oct;35(4):361-7
1721565
Ann Surg. 1989 Oct;210(4):513-24; discussion 524-5
2802836
Br J Surg. 1990 Feb;77(2):214-8
2107958
J Chromatogr B Biomed Appl. 1995 Aug 4;670(1):29-36
7493081
N Engl J Med. 1999 Sep 9;341(11):785-92
10477776
World J Surg. 1999 Jun;23(6):545-52
10227922
Metabolism. 1985 Jul;34(7):665-9
4010525
Crit Care Med. 2008 Jun;36(6):1707-13
18496372
Ann Surg. 1996 Apr;223(4):420-7
8633921
Arch Surg. 1988 Nov;123(11):1409-14
3178489
Acta Paediatr Scand Suppl. 1991;372:97-105; discussion 106
1927524
J Clin Endocrinol Metab. 1997 Feb;82(2):421-8
9024230
Am J Physiol. 1994 Oct;267(4 Pt 1):E591-8
7943309
J Clin Invest. 2003 Dec;112(12):1788-90
14679173
J Surg Res. 1991 Dec;51(6):472-6
1943083
Surgery. 1990 Aug;108(2):161-4
2382218
Ann Surg. 1994 Jul;220(1):19-24
8024354
Annu Rev Med. 1975;26:427-41
167653
Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E226-33
10662706
Infusionsther Klin Ernahr. 1986 Aug;13(4):162-5
3531008
Symp Soc Exp Biol. 1992;46:319-30
1341045
Endocr Rev. 1994 Feb;15(1):80-101
8156941
Eur J Clin Invest. 1995 Oct;25(10):784-92
8557066
J Endocrinol. 2000 Nov;167(2):331-8
11054648
Nutr Metab (Lond). 2007 Jan 09;4:2
17212815
Ann Surg. 1995 Nov;222(5):646-53
7487212
Horm Res. 1994;42(1-2):66-71
7959637
Ann Surg. 1989 Apr;209(4):455-61
2494960
J Cardiothorac Vasc Anesth. 2003 Aug;17(4):470-7
12968235
JPEN J Parenter Enteral Nutr. 1995 Sep-Oct;19(5):333-40
8577008
Surgery. 2001 May;129(5):576-86
11331450
Br J Surg. 1990 Jul;77(7):785-90
2116934
Br J Surg. 1995 Jul;82(7):921-5
7544219
Ann Surg. 1990 Oct;212(4):424-9; discussion 430-1
2121109
Metabolism. 1993 Feb;42(2):185-90
8474315
Am J Physiol. 1994 Aug;267(2 Pt 1):E331-6
8074213
Ann Surg. 1987 Jul;206(1):56-61
3606231